Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.

Item
http://www.wikidata.org/entity/Q43578102
The use of statins in optimising reduction of cardiovascular risk: focus on fluvastatin.Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP ExpressionEffect of lipid-lowering drug therapy on small-dense low-density lipoprotein.Low-density lipoprotein size and cardiovascular risk assessment.The clinical relevance of low-density-lipoproteins size modulation by statins.Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.The role of statin drugs in the management of the peripheral vascular patient.Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (prDifferential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.Long-term effects of statins on arterial pressure and stiffness of hypertensives.Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy.
P2860

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.

Item
http://www.wikidata.org/entity/Q43578102
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@en
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@nl
type
label
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@en
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@nl
prefLabel
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@en
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Fluvastatin lowers atherogenic ...... rogenic lipoprotein phenotype.
@en
P2093
P304
P31
P356
10.1161/01.CIR.103.15.1942
P407
P433
P478
P50
P577
P698
P921